Voiding dysfunction in patients with Parkinson's disease: Impact of neurological impairment and clinical parameters

Neurourology and Urodynamics

Volumn 28, Issue 6, 2009, Pages 510-515

  Sammour, Zein M ^a   Gomes, Cristiano M ^a   Barbosa, Egberto R ^a   Lopes, Roberto I ^a   Sallem, Flávio S ^a   Trigo Rocha, Flavio E ^a   Bruschini, Homero ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bladder dysfunction; Etiology; Parkinson's disease

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; IMPAIRED BLADDER EMPTYING; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MORBIDITY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NOCTURIA; PARKINSON DISEASE; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK FACTOR; URGE INCONTINENCE; URINARY FREQUENCY; URINARY URGENCY;

ADULT; AGE FACTORS; AGED; ANTIPARKINSON AGENTS; DISABILITY EVALUATION; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; URINARY BLADDER; URINARY BLADDER DISEASES;

EID: 70049117344     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20681     Document Type: Article

References (22)

1. Araki I, Kuno S. Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score. J Neurol Neurosurg Psychiatry 2000;68:429-33.
2. Hattori T, Yasuda K, Kita K, et al. Voiding dysfunction in Parkinson's disease. Jpn J Psychiatry Neurol 1992;46:181-6.
3. Sakakibara R, Shinotoh H, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 2001;92:76-85.
4. Winge K, Friberg L, Werdelin L, et al. Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease. Eur J Neurol 2005;12:842-50.
5. Campos-Sousa RN, Quagliato E, da Silva BB, et al. Urinary symptoms in Parkinson's disease: Prevalence and associated factors. Arq Neuropsiquiatr 2003;61:359-63.
6. Hobson P, Islam W, Roberts S, et al. The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls. Parkinsonism Relat Disord 2003;10:67-71.
7. Lemack GE, Dewey RB, Jr, Roehrborn CG, et al. Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease. Urology 2000;56:250-4.
8. Sakakibara R, Hattori T, Uchiyama T, et al. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2001;71:600-6.
9. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-9.
10. Fahn S, Elton RL. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information; 1987. p. 153-63.
11. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality. Neurology 1967;17:427-42.
12. Donovan JL, Peters TJ, Abrams P, et al. Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol 2000;164:1948-55.
13. Araki I, Kitahara M, Oida T, et al. Voiding dysfunction and Parkinson's disease: Urodynamic abnormalities and urinary symptoms. J Urol 2000;164: 1640-3.
14. Winge K, Skau AM, Stimpel H, et al. Prevalence of bladder dysfunction in Parkinsons disease. Neurourol Urodyn 2006;25:116-22.
15. Jacobsen SJ, Guess HA, Panser L, et al. A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County study of urinary symptoms and health status among men. Arch Fam Med 1993;2:729-35.
16. Reggio E, de BJ, Jr, Junqueira RG, et al. Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening. Int J Impot Res 2007;19:492-5.
17. Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: Prevalence and impact on daily life. Clin Auton Res 2005;15:76-82.
18. Herschorn S, Gajewski J, Schulz J, et al. A population-based study of urinary symptoms and incontinence: The Canadian Urinary Bladder Survey. BJU Int 2008;101:52-8.
19. Schatzl G, Temml C, Waldmuller J, et al. A comparative cross-sectional study of lower urinary tract symptoms in both sexes. Eur Urol 2001;40: 213-9.
20. Brusa L, Petta F, Pisani A, et al. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease. Neurology 2007;68:1455-9.
21. Roehrborn CG, McConnell JD. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's urology. Philadelphia: W.B. Saunders Co; 2002. p. 1297-330.
22. Hassler E, Krakau I, Haggarth L, et al. Questioning questions about symptoms of benign prostatic hyperplasia. Fam Pract 2001;18:328-32.